206 related articles for article (PubMed ID: 29765307)
1. A Novel Integrative Mechanism in Anxiolytic Behavior Induced by Galanin 2/Neuropeptide Y Y1 Receptor Interactions on Medial Paracapsular Intercalated Amygdala in Rats.
Narváez M; Borroto-Escuela DO; Santín L; Millón C; Gago B; Flores-Burgess A; Barbancho MA; Pérez de la Mora M; Narváez J; Díaz-Cabiale Z; Fuxe K
Front Cell Neurosci; 2018; 12():119. PubMed ID: 29765307
[TBL] [Abstract][Full Text] [Related]
2. Galanin and neuropeptide Y interactions elicit antidepressant activity linked to neuronal precursor cells of the dentate gyrus in the ventral hippocampus.
Borroto-Escuela DO; Pita-Rodriguez M; Fores-Pons R; Barbancho MA; Fuxe K; Narváez M
J Cell Physiol; 2021 May; 236(5):3565-3578. PubMed ID: 33044017
[TBL] [Abstract][Full Text] [Related]
3. Galanin receptor 2-neuropeptide Y Y1 receptor interactions in the amygdala lead to increased anxiolytic actions.
Narváez M; Millón C; Borroto-Escuela D; Flores-Burgess A; Santín L; Parrado C; Gago B; Puigcerver A; Fuxe K; Narváez JA; Díaz-Cabiale Z
Brain Struct Funct; 2015 Jul; 220(4):2289-301. PubMed ID: 24841617
[TBL] [Abstract][Full Text] [Related]
4. Galanin receptor 2-neuropeptide Y Y1 receptor interactions in the dentate gyrus are related with antidepressant-like effects.
Narváez M; Borroto-Escuela DO; Millón C; Gago B; Flores-Burgess A; Santín L; Fuxe K; Narváez JA; Díaz-Cabiale Z
Brain Struct Funct; 2016 Nov; 221(8):4129-4139. PubMed ID: 26666529
[TBL] [Abstract][Full Text] [Related]
5. Intranasal Delivery of Galanin 2 and Neuropeptide Y1 Agonists Enhanced Spatial Memory Performance and Neuronal Precursor Cells Proliferation in the Dorsal Hippocampus in Rats.
Borroto-Escuela DO; Fores R; Pita M; Barbancho MA; Zamorano-Gonzalez P; Casares NG; Fuxe K; Narváez M
Front Pharmacol; 2022; 13():820210. PubMed ID: 35250569
[TBL] [Abstract][Full Text] [Related]
6. Long-term enhancements in antidepressant efficacy and neurogenesis: Effects of intranasal co-administration of neuropeptide Y 1 receptor (NPY1R) and galanin receptor 2 (GALR2) agonists in the ventral hippocampus.
Beltran-Casanueva R; Hernández-García A; Serrano-Castro PJ; Sánchez-Pérez JA; Barbancho-Fernández MA; García-Casares N; Fuxe K; Borroto-Escuela DO; Narváez M
FASEB J; 2024 Apr; 38(7):e23595. PubMed ID: 38572811
[TBL] [Abstract][Full Text] [Related]
7. Enhanced neuronal survival and BDNF elevation via long-term co-activation of galanin 2 (GALR2) and neuropeptide Y1 receptors (NPY1R): potential therapeutic targets for major depressive disorder.
Borroto-Escuela D; Serrano-Castro P; Sánchez-Pérez JA; Barbancho-Fernández MA; Fuxe K; Narváez M
Expert Opin Ther Targets; 2024 Apr; 28(4):295-308. PubMed ID: 38622072
[TBL] [Abstract][Full Text] [Related]
8. Preferential activation by galanin 1-15 fragment of the GalR1 protomer of a GalR1-GalR2 heteroreceptor complex.
Borroto-Escuela DO; Narvaez M; Di Palma M; Calvo F; Rodriguez D; Millon C; Carlsson J; Agnati LF; Garriga P; Díaz-Cabiale Z; Fuxe K
Biochem Biophys Res Commun; 2014 Sep; 452(3):347-53. PubMed ID: 25152404
[TBL] [Abstract][Full Text] [Related]
9. Decreased medial prefrontal cortex activity related to impaired novel object preference task performance following GALR2 and Y1R agonists intranasal infusion.
Díaz-Sánchez E; López-Salas A; Mirchandani-Duque M; Alvarez-Contino JE; Sánchez-Pérez JA; Fuxe K; Borroto-Escuela DO; García-Casares N; Narváez M
Biomed Pharmacother; 2023 May; 161():114433. PubMed ID: 36848750
[TBL] [Abstract][Full Text] [Related]
10. GALR2 and Y1R agonists intranasal infusion enhanced adult ventral hippocampal neurogenesis and antidepressant-like effects involving BDNF actions.
Alvarez-Contino JE; Díaz-Sánchez E; Mirchandani-Duque M; Sánchez-Pérez JA; Barbancho MA; López-Salas A; García-Casares N; Fuxe K; Borroto-Escuela DO; Narváez M
J Cell Physiol; 2023 Feb; 238(2):459-474. PubMed ID: 36599082
[TBL] [Abstract][Full Text] [Related]
11. Region specific galanin receptor/neuropeptide Y Y1 receptor interactions in the tel- and diencephalon of the rat. Relevance for food consumption.
Parrado C; Díaz-Cabiale Z; García-Coronel M; Agnati LF; Coveñas R; Fuxe K; Narváez JA
Neuropharmacology; 2007 Feb; 52(2):684-92. PubMed ID: 17087983
[TBL] [Abstract][Full Text] [Related]
12. NPY-Y
Vázquez-León P; Ramírez-San Juan E; Marichal-Cancino BA; Campos-Rodríguez C; Chávez-Reyes J; Miranda-Páez A
Pharmacol Biochem Behav; 2020 Dec; 199():173071. PubMed ID: 33171140
[TBL] [Abstract][Full Text] [Related]
13. Antisense inhibition of neuropeptide Y (NPY)-Y1 receptor expression blocks the anxiolytic-like action of NPY in amygdala and paradoxically increases feeding.
Heilig M
Regul Pept; 1995 Oct; 59(2):201-5. PubMed ID: 8584755
[TBL] [Abstract][Full Text] [Related]
14. Understanding the role of heteroreceptor complexes in the central nervous system.
Fuxe K; Borroto-Escuela D; Fisone G; Agnati LF; Tanganelli S
Curr Protein Pept Sci; 2014; 15(7):647. PubMed ID: 25256022
[TBL] [Abstract][Full Text] [Related]
15. Galanin receptor/neuropeptide y receptor interactions in the central nervous system.
Díaz-Cabiale Z; Flores-Burgess A; Parrado C; Narváez M; Millón C; Puigcerver A; Coveñas R; Fuxe K; Narváez JA
Curr Protein Pept Sci; 2014; 15(7):666-72. PubMed ID: 25175455
[TBL] [Abstract][Full Text] [Related]
16. Analgesic and anxiolytic effects of [Leu
Vázquez-León P; Mendoza-Ruiz LG; Juan ER; Chamorro-Cevallos GA; Miranda-Páez A
Neuropeptides; 2017 Dec; 66():81-89. PubMed ID: 29042065
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptide Y Y1 receptors in the central nucleus of amygdala mediate the anxiolytic-like effect of allopregnanolone in mice: Behavioral and immunocytochemical evidences.
Deo GS; Dandekar MP; Upadhya MA; Kokare DM; Subhedar NK
Brain Res; 2010 Mar; 1318():77-86. PubMed ID: 20059983
[TBL] [Abstract][Full Text] [Related]
18. Anxiogenic-like effect of the NPY Y1 receptor antagonist BIBP3226 administered into the dorsal periaqueductal gray matter in rats.
Kask A; Rägo L; Harro J
Regul Pept; 1998 Sep; 75-76():255-62. PubMed ID: 9802417
[TBL] [Abstract][Full Text] [Related]
19. Anxiolytic action of group II and III metabotropic glutamate receptors agonists involves neuropeptide Y in the amygdala.
Wierońska JM; Szewczyk B; Pałucha A; Brański P; Zieba B; Smiałowska M
Pharmacol Rep; 2005; 57(6):734-43. PubMed ID: 16382191
[TBL] [Abstract][Full Text] [Related]
20. Anxiolytic-like action of neuropeptide Y: mediation by Y1 receptors in amygdala, and dissociation from food intake effects.
Heilig M; McLeod S; Brot M; Heinrichs SC; Menzaghi F; Koob GF; Britton KT
Neuropsychopharmacology; 1993 Jun; 8(4):357-63. PubMed ID: 8099792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
